✦ LIBER ✦

497 An open-label, multicenter study of the efficacy and safety of peginterferon alfa-2A (40KD) (PEGASYS®), alone or in combination with ribavirin (COPEGUS®), in patients with HIV/HCV coinfection

✍ Scribed by E. Ortega; A. Martin; C. Barros; K. Aguirrebengoa; J. Gonzalez; A. Garcia; R. Rubio; F. Pulido

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, multicenter study of effi

✍ E. Ortega; C. Barros; F. Pulido; R. Rubio; J.A. Garcia; K. Aguirrebengoa; V. Ase 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Predictors of virologic relapse in patie

✍ V. Balan; S. Zeuzem; H. Sette; M. Fried; D. Jensen; G. Pastore; P. Marcellin; F. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 151 KB

697 AN OPEN-LABEL, COMPARATIVE, MULTICEN

✍ C.-J. Liu; W.-L. Chuang; C.-M. Lee; S.-S. Wu; L.-Y. Liao; H.-T. Kuo; Y.-C. Chao; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Treatment of patients with chronic hepat

✍ M. Swain; M.-Y. Lai; M.L. Shiffman; W.G. Cooksley; A. Abergel; M. Diago; M. Brun 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Efficacy of safety of therapy with inter

✍ J.A. Galeras; C. Tural; L. Force; S. Montoliu; J.A. Rodriguez de Castro; S. Coll 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 165 KB

507 Early prediction of sustained virolo

✍ M. Rodriguez-Torres; F.J. Torriani; E. Lissen; N. Brau; M. Sulkowski; R. Sola; B 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB